Lifestyle Medicine Summit & CPP Annual Meeting at the LEAD Conference

Date/Time
Date(s) - October 14, 2022 - October 15, 2022
9:00 am - 11:30 pm


Join us at the Lifestyle Medicine Summit and CPP Annual Meeting to be held during the NCMS LEAD Conference, October 14-15, 2022

Learn more about how you can engage and empower your patients to improve their well-being during this two-day event that features 15 speakers who are experts in their field.

If your interests are geared toward addressing social determinants of health and empowering your patients to make lifestyle changes for better health, the Lifestyle Medicine Summit is for you. This optional track will be taking place during the LEAD Conference at the Raleigh Marriott Crabtree Valley as well. This track is eligible for up to 7.0 AMA PRA Category 1 Credit(s)TM

Download the agenda.

LEARN MORE AND REGISTER TODAY!

________________________________________

Accreditation

Lifestyle Medicine Summit – Credit Statement
Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Accreditation
In support of improving patient In support of improving patient care, the Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
Disclosure Statement
Duke University Health System Department of Clinical Education and Professional Development adheres to ACCME Essential Areas and Policies regarding industry support of continuing medical education. Disclosures of faculty/planning committee members and commercial relationships will be made known at the activity. Speakers are also expected to openly disclose a discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.